150712-24-6Relevant articles and documents
5- OR 7-AZAINDAZOLES AS BETA-LACTAMASE INHIBITORS
-
Page/Page column 41; 43; 44, (2020/09/19)
The present invention relates to β-lactamase inhibitors having the following general formula (I): wherein R1-R4 and X1-X2 are defined in the specification, pharmaceutical composition thereof, and use thereof for the treatment of a bacterial infection, alone or in combination with β-lactam antibiotics and/or other antibiotics and/or other β-lactamase inhibitors.
PYRROLOTRIAZINE KINASE INHIBITORS
-
Page/Page column 59-60, (2010/04/28)
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula (I) compounds inhibit tyrosine kinase activity of such as Jak2 and CK2, thereby making them useful as antiproliferative agents for the treat
HETEROCYCLIC COMPOUNDS AS INHIBITORS OF CXCR2
-
Page/Page column 29, (2009/10/21)
The present invention relates to compounds of formula (I) wherein R1, R2, X, Y and Z are as defined in the specification.
5-SULFANYLMETHYL-PYRAZOLO [1,5-A] PYRIMIDIN-7-OL DERIVATIVES AS CXCR2 ANTAGONISTS
-
Page/Page column 20, (2008/12/05)
The present invention relates to compounds of formula (I) and the use of these compounds as pharmaceuticals, e.g. in preventing or treating a CXCR2 receptor mediated condition or disease.
PYRROLOTRIAZINE KINASE INHIBITORS
-
Page/Page column 15, (2008/06/13)
The present invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity of such as TrkA, TrkB, TrkC, Jak2, Jak3 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
PYRAZOLE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSYNE KINASES
-
Page/Page column 99, (2008/06/13)
Compounds of formula (I): and their use in the inhibition of Trk activity are described.
3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
-
, (2008/06/13)
The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.